Lorglumide Sodium Salt is a potent, non-peptide antagonist of the cholecystokinin (CCK1 or CCKA) receptor, utilized extensively in research to investigate gastrointestinal physiological functions, including… Read more
Lorglumide Sodium Salt is a potent, non-peptide antagonist of the cholecystokinin (CCK1 or CCKA) receptor, utilized extensively in research to investigate gastrointestinal physiological functions, including gut muscle contraction, pancreatic secretion, and pancreatic growth. Pharmaceutical laboratories rely on accurate reference standards for this compound to conduct rigorous analytical testing and method validation. This category provides essential materials for comprehensive quality control assessments, including pharmacopeial and non-pharmacopeial impurities, as well as stable isotope-labelled standards. These high-purity compounds are critical for impurity profiling and structural integrity verification, enabling researchers to ensure accuracy during advanced chromatographic and spectroscopic analyses. By incorporating these specialized reference materials into study protocols, laboratories can effectively characterize the parent compound and its related substances, supporting precise and reproducible investigations into cholecystokinin receptor pathways and their associated pharmacological applications.